Session 9: Adjuvant endocrine therapy for premenopausal women: Risk stratification, type & duration
Adjuvant endocrine therapy for premenopausal women: Risk stratification, type, & duration (Prudence Francis, Australia)Recorded Friday, March 22 at the 16th St. Gallen International Breast Cancer Conference
Primary Therapy of Early Breast Cancer Vienna, Austria 20 - 23 March 2019
More info: http://oncoletter.ch
Видео Session 9: Adjuvant endocrine therapy for premenopausal women: Risk stratification, type & duration канала Oncoletter
Primary Therapy of Early Breast Cancer Vienna, Austria 20 - 23 March 2019
More info: http://oncoletter.ch
Видео Session 9: Adjuvant endocrine therapy for premenopausal women: Risk stratification, type & duration канала Oncoletter
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
How to use endocrine therapy in premenopausal women with ER+ early breast cancer
Raising the Bar in HER2-Positive Breast Cancer
Endocrine Therapy, Tamoxifen & Aromatase Inhibitors
Advances in Immunotherapy for Melanoma
Having radiotherapy for breast cancer - Part Two: Having Treatment
Basis for immunotherapy in lung cancer
Incidence, Timing, and Survival of Second Primary Lung Cancer in Patients in the National Lung S...
Progression Free Survival and Overall Survival in NADIM II Study — Dr. Mariano Provencio
Short Review: General Overview of Invasive Lobular Carcinoma (Breast)
Understanding Pathology for Breast Cancer
Clinical Advances for Metastatic Prostate Cancer
Breast Cancer Treatment Trends for 2022
The latest in stem cell medicine | Mark Noble | TEDxRochester
Mushrooms as Medicine with Paul Stamets at Exponential Medicine
Menopause and Midlife Health (Hormone Therapy)![Results from an International Randomized Phase III Trial (CALGB 140503 [Alliance])—Dr. Nasser Al...](https://i.ytimg.com/vi/HtTcQS1Efu4/default.jpg)
Results from an International Randomized Phase III Trial (CALGB 140503 [Alliance])—Dr. Nasser Al...
Stem Cells and the Future of Medicine - Research on Aging
DCIS Diagnosis & The Oncotype Breast Cancer Assay for DCIS
IASLC Early Detection and Screening Committee to Report on global obstacles to lung cancer scree...
WCLC 2022 Highlights: Prof. Solange Peters, CHUV, Lausanne & President, European Society for Med...